Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ofloxacin: a review.

M A Smythe1, M J Rybak

  • 1Wayne State University, Detroit, MI 48202.

DICP : the Annals of Pharmacotherapy
|November 1, 1989
PubMed
Summary

Ofloxacin, a broad-spectrum fluoroquinolone antibiotic, shows efficacy against various bacterial infections, including respiratory and urinary tract infections. Clinical trials indicate mild side effects and no significant drug interactions, positioning it as a promising treatment option.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multicenter Study of the Real-World Use of Ceftaroline versus Vancomycin for Acute Bacterial Skin and Skin Structure Infections.

Antimicrobial agents and chemotherapy·2019
Same author

Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis.

Antimicrobial agents and chemotherapy·2017
Same author

Defining daptomycin resistance prevention exposures in vancomycin-resistant Enterococcus faecium and E. faecalis.

Antimicrobial agents and chemotherapy·2014
Same author

Novel combinations of vancomycin plus ceftaroline or oxacillin against methicillin-resistant vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA.

Antimicrobial agents and chemotherapy·2013
Same author

Independent risk factors for the co-colonization of vancomycin-resistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus in the region most endemic for vancomycin-resistant Staphylococcus aureus isolation.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2013
Same author

Successful treatment of a left ventricular assist device infection with daptomycin non-susceptible methicillin-resistant Staphylococcus aureus: case report and review of the literature.

Transplant infectious disease : an official journal of the Transplantation Society·2012

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Microbiology

Background:

  • Ofloxacin is a novel fluoroquinolone antibiotic.
  • It exhibits broad-spectrum activity against Gram-positive and Gram-negative bacteria.
  • Includes activity against resistant strains like MRSA and challenging pathogens like M. tuberculosis.

Purpose of the Study:

  • To review the efficacy and safety of ofloxacin.
  • To explore potential new indications for quinolone antibiotics.
  • To summarize clinical trial findings for ofloxacin.

Main Methods:

  • Review of clinical trial data.
  • Analysis of microbiological spectrum of activity.
  • Assessment of adverse effects and drug interactions.

Main Results:

  • Ofloxacin demonstrates broad-spectrum activity against Enterobacteriaceae, P. aeruginosa, MRSA, N. gonorrhoeae, C. trachomatis, and M. tuberculosis.
  • Clinical trials confirm efficacy in treating lower respiratory tract infections, urinary tract infections, and STDs.
  • Adverse effects are generally mild (GI, CNS, hypersensitivity); no significant drug interactions reported.

Conclusions:

  • Ofloxacin is an effective antibiotic with a favorable safety profile.
  • Its broad spectrum and efficacy suggest potential for expanded therapeutic uses.
  • Ofloxacin represents a valuable option for treating various bacterial infections.

Related Experiment Videos